Metro Healthcare Indonesia Tbk. vs Ciputra Development Tbk — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 108.5K 24h volume), while Ciputra Development Tbk trades at Rp575 (market cap 10.38T, 7.88M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is the larger of the two by market cap, and Ciputra Development Tbk is more actively traded (7.88M versus 108.5K). Which is the better fit depends on your goals.
| CARE | CTRA | |
|---|---|---|
Market Cap | 14.23T | 10.38T |
Volume | 108.5K | 7.88M |
Lot | 1.09K | 78.76K |
Turnover | 46.35M | 4.51B |
Average Price | 427.16 | 572.98 |
Value | 46.35M | 4.51B |
Indicative Equilibrium Price | 428 | 565 |
Indicative Equilibrium Volume | 400 | 819 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →